A recently published decision of the Court of Turin in the case Merck Sharpe & Dohme versus Sandoz (decision of 7 April 2011), concerning dorzolamide hydrochloride timolol maleate eye drops,…
The Swiss company Bobst (hereinafter referred to as “Bobst”) is the holder of European patent No. 1 170 228 relating to a “device for controlling the means for feeding sheets in a…
The smartphone wars appear to be continuing unabated in much of the developed world. In July 2011, Apple commenced infringement proceedings against HTC in Germany in respect of three patents (two in…
The gentle reader of this blog knows that on January 1, 2012 the new Federal Patent Court will take up work in Switzerland. As Switzerland's court of first instance in matters dealing with patents,…
Part 1 of the drama with the title "You Shall not Lie" is covered by a previous post.Part 2 has been briefly summarized two weeks ago by Miriam.
It appeared to me that the potential consequences of…
Vetrotech Saint-Gobain (International) (hereinafter referred to as “Vetrotech”) is the holder of European patent No. 0 620 781 designating France, filed on 5 August 1993 and granted on 19 May 1999,…
As the readers will know, the complex architecture of the European patent system allows third parties to challenge the validity of a patent by filing an opposition before the European Patent Office…
On 24 May 2011, the European Commission published the "Proposal for a Regulation concerning customs enforcement of intellectual property rights" (SEC(2011)597 final) to replace the present Regulation…
The Danish Supreme Court upheld the Maritime and Commercial Court's decision revoking an injunction against Teva issued by the Danish High Court. The Supreme Court ruled that a condition for the…
Contrary to the decision of the Opposition Division issued two weeks later, the District Court of The Hague held Novozymes’ patent to be novel and inventive. It also held the patent indirectly…
